TickerFacts.

Allarity Therapeutics, Inc. (ALLR): Revenue

Annual figures by period end, from SEC filings.

$320.0K
Year ended 2025-12-31
$345.0K
Trailing 12 months to 2026-06-30
2024-12-31: $02025-12-31: $320.0K$320.0K
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$320.0Kn/a2026-03-30, From 2025-01-01
2024-12-31$0n/a2026-03-30, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Allarity Therapeutics, Inc. (ALLR)2025-12-31$320.0Kn/a
Vyome Holdings, Inc (HIND)2025-12-31$319.7K+24.4%
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31$336.1K-45.5%
Abvc Biopharma, Inc. (ABVC)2025-12-31$296.0K-41.9%
America Great Health (AAGH)2025-06-30$391.7K+32.9%
Can-Fite BioPharma Ltd. (CANF)2025-12-31$405.0K-39.9%
Medicinova Inc (MNOV)2025-12-31$409.7Kn/a
Scienture Holdings, Inc. (SCNX)2025-12-31$431.6K+215.9%
Regen BioPharma Inc (RGBP)2025-09-30$236.6K0.0%

Compare ALLR, HIND, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗